BiopharmaTrend.com

SEngine Precision Medicine

SEngine Precision Medicine

Private company
SENGINE PRECISION MEDICINE
Seattle

SEngine Precision Medicine has engineered an innovative approach to identify and develop the next generation of cancer targeted drugs. Built on its Founders’ work of more than 25 years at the Fred Hutchinson Cancer Research Center, SEngine employs functional genomics and robotic testing of drugs in live patient organoids to match newly developed drugs to individual cancer patients. SEngine strives to fulfill the promise of personalized medicine providing cancer patients with effective, targeted, and less-toxic treatments.


Founded
2015
Status
Private company
Geography
United States of America based
Funding
$11.200 M
Research papers
8

Products

PARIS® Test

The PARIS® Test is the antidote for today's failing standard of care. DNA sequencing alone predicts effective treatment an estimated …

Read more

Services

No services posted yet


This data is part of our proprietary analytics report:

This service is currently only supported on the desktop screens, please, use this service from your desktop or laptop for correct visualization and functionality

Go to home page